Canada Life
BNTX icon

Canada Life’s BioNTech BNTX Stock Holding History

Canada Life’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Sell
7,362
-2,240
-23% -$211K ﹤0.01% 1445
2026
Q1 		$856K Buy
9,602
+5
+0.1% +$514 ﹤0.01% 1395
2025
Q4 		$913K Buy
9,597
+45
+0.5% +$4.53K ﹤0.01% 1405
2025
Q3 		$935K Buy
9,552
+933
+11% +$99.8K ﹤0.01% 1459
2025
Q2 		$919K Buy
8,619
+414
+5% +$41.8K ﹤0.01% 1455
2025
Q1 		$749K Buy
8,205
+414
+5% +$46.4K ﹤0.01% 1508
2024
Q4 		$887K Buy
7,791
+3,025
+63% +$345K ﹤0.01% 1508
2024
Q3 		$566K Buy
4,766
+160
+3% +$14.7K ﹤0.01% 1650
2024
Q2 		$370K Buy
4,606
+1,180
+34% +$108K ﹤0.01% 1741
2024
Q1 		$316K Buy
3,426
+1,518
+80% +$146K ﹤0.01% 1768
2023
Q4 		$200K Sell
1,908
-860
-31% -$86.7K ﹤0.01% 1843
2023
Q3 		$302K Buy
2,768
+1,787
+182% +$198K ﹤0.01% 1788
2023
Q2 		$106K Sell
981
-7
-0.7% -$787 ﹤0.01% 1921
2023
Q1 		$123K Buy
988
+464
+89% +$63.7K ﹤0.01% 1952
2022
Q4 		$79K Buy
524
+60
+13% +$9.23K ﹤0.01% 2019
2022
Q3 		$62K Buy
464
+46
+11% +$7.03K ﹤0.01% 2063
2022
Q2 		$62K Sell
418
-1,623
-80% -$248K ﹤0.01% 2012
2022
Q1 		$371K Buy
2,041
+1,713
+522% +$288K ﹤0.01% 1776
2021
Q4 		$84K Buy
328
+44
+15% +$12.1K ﹤0.01% 2043
2021
Q3 		$78K Buy
+284
New +$90.3K ﹤0.01% 2110

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Canada Life's BNTX Position: Q2 2026 in Review

Canada Life reduced its BioNTech (BNTX) stake by 23% in Q2 2026, selling an estimated $211K and leaving 7,362 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Canada Life first reported a position in BNTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $935K in Q3 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Canada Life held 7,362 shares of BioNTech worth $685K as of Q2 2026.
  • Canada Life sold 2,240 BioNTech shares in Q2 2026, an estimated $211K.
  • BioNTech made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1445 holding.
  • Canada Life first reported a position in BioNTech in Q3 2021 and has held it in 20 quarters since.
  • Canada Life's BioNTech position peaked at $935K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.